Mepartricin

DB13633InvestigationalSmall molecule

Mepartricin is a medication indicated in the treatment of benign prostatic hyperplasia, vaginal candidiasis, or trichomoniasis. A medication used to treat certain vaginal infections or an enlarged prostate.

Resolves to

Compound

UNIIB7FBW3Y74GCAS11121-32-7

Clinical / RWD

ATCA01AB16ATCD01AA06ATCG01AA09

What you can answer from here — as of March 06, 2025

174Drug interactionsStructured to mechanism, not free text

3Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

9Marketed productsAcross 1 country and 1 labeller

4ATC codesIncluding every combination product, plus 22 drug categories

2+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Mepartricin, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account